CSIMarket


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 

Oramed Pharmaceuticals Inc

ORMP's Fundamental analysis






Oramed Pharmaceuticals Inc 's sales fell by -1.03 % in I. Quarter 2021 from the same quarter a year ago. Ranking at No. 50

Major Pharmaceutical Preparations industry recorded growth of revenues by 178.07 %

Oramed Pharmaceuticals Inc 's net income grew by 170.29 % in I. Quarter 2021 year on year, above company average,

More on ORMP's Growth


Oramed Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Oramed Pharmaceuticals Inc PEG ratio is at 0.33 Oramed Pharmaceuticals Inc realized cash outflow of $ -0.2per share in trailing twelve-month period.
Company
11.28
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 121.36.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.97.


More on ORMP's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 4.65

Oramed Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Oramed Pharmaceuticals Inc PEG ratio is at 0.33 Oramed Pharmaceuticals Inc realized cash outflow of $ -0.2per share in trailing twelve-month period.
Company
11.28
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 121.36.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.97.

Oramed Pharmaceuticals Inc Price to Book Ratio is at 1.92 lower than Indusry Avg. of 1465.05. and higher than S&P 500 Avg. of -0

More on ORMP's Valuation

  Market Capitalization (Millions $) 327
  Shares Outstanding (Millions) 37
  Employees -
  Revenues (TTM) (Millions $) 3
  Net Income (TTM) (Millions $) 24
  Cash Flow (TTM) (Millions $) -7
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 4.65

  Market Capitalization (Millions $) 327
  Shares Outstanding (Millions) 37
  Employees -
  Revenues (TTM) (Millions $) 3
  Net Income (TTM) (Millions $) 24
  Cash Flow (TTM) (Millions $) -7
  Capital Exp. (TTM) (Millions $) -

ORMP's Profitability Comparisons
Oramed Pharmaceuticals Inc achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2021 to 1195.85 % from 898.38 % in III. Quarter.

Oramed Pharmaceuticals Inc net profit margin of 1201.48 % is currently ranking no. 3 in Major Pharmaceutical Preparations industry, ranking no. 4 in Healthcare sector and number 4 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 20.23
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.07
  Asset Turnover Ratio (TTM) 0.03
  Inventory Turnover Ratio (TTM) -



Oramed Pharmaceuticals Inc achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2021 to 1195.85 % from 898.38 % in III. Quarter.

Oramed Pharmaceuticals Inc net profit margin of 1201.48 % is currently ranking no. 3 in Major Pharmaceutical Preparations industry, ranking no. 4 in Healthcare sector and number 4 in S&P 500.

More on ORMP's Key Ratios





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TECR's Profile

Stock Price

TECR's Financials

Business Description

Fundamentals

Charts & Quotes

TECR's News

Suppliers

TECR's Competitors

Customers & Markets

Economic Indicators

TECR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071